Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 193
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Bridging International Borders to Fight Re-emerging Plague in Madagascar

    The Plague is considered one of the most successful infectious agents in history and at one point killed nearly...

    Understanding the perspective of women who use the Billings Ovulation Method

    Fertility awareness-based methods (FABM) are a group of family planning methods that teach women how to identify...

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    Backer Badge Funded